
Opinion|Videos|February 17, 2025
Strategies for Optimizing Therapy
Panelists discuss how barriers to optimizing TD therapy include insurance coverage limitations, high medication costs, delayed diagnosis, lack of provider awareness, and stigma associated with movement disorders, while highlighting strategies like patient assistance programs, early screening protocols, provider education initiatives, and collaborative care models to overcome these obstacles and improve access to effective treatment.
Advertisement
Episodes in this series

Video series above is prompted by the following:
- What are common barriers that prevent the optimization of therapy for TD, and what strategies do you utilize to overcome these barriers?
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA, HHS Move to Accelerate Biosimilar Approvals
2
Accelerated Approval of Cancer Drugs: Benefit or Burden?
3
COVID-19 mRNA Vaccines May Boost Immunotherapy Response in Cancer
4
Pharmacists Lead the Way in Evolving CAR T-Cell and Bispecific Antibody Therapy Management
5

















































































































































































































